Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acute necrotizing encephalitis
adverse drug reaction
altered states of consciousness
amphiphysin antibodies
analgesic
antiviral agents
ataxia, cerebellar
atypical
autoantibodies
autoimmune disease
autonomic neuropathy
axonal degeneration
B cell lymphocyte depletion
B cell lymphocytes
bacterial infection
bacterial infection, CNS
behavioral disorder
Borrelia burgdorferi infection
brain biopsy
brain scan
calcification, intracranial
campylobacter infection
carcinoma
carcinoma of lung
cataracts, congenital
central nervous system, infection of
cerebellar degeneration
cerebrospinal fluid
cerebrospinal fluid, culture of
cerebrospinal fluid, cytology
cerebrospinal fluid, gammaglobulin of
cerebrospinal fluid, oligoclonal IgG in
cerebrospinal fluid, xanthochromia of
children
chlamydia infection
chorioretinitis
chronic fatigue syndrome
collapsin response mediator protein 5 IgG
concentration, impaired
confusion
contactin associated protein like 2 antibodies
controversies in neurology
cost
cyst, porencephalic
cytomegalic inclusion disease
cytosine arabinoside
demyelinating disease
depression
depression, psychotic
dermatomyositis
diabetes mellitus
diarrhea
disability rating scale, neurological
disability, neurological
down-beat nystagmus
drug induced neurologic disorders
electrical injury of nervous system
electroencephalogram
electroencephalogram, abnormalities of
electron microscopy
ELISA
encephalitis
encephalitis, autoimmune
encephalitis, brainstem
encephalitis, paraneoplastic
encephalomyelitis
epidemiology of neurology
episodic disorders
Epstein-Barr virus
ergotamine
etanercept
facial nerve palsy
familial
fatigue
fellowship training
fever
Fisher's syndrome
flu-like illness
gadolinium
gait disorder
gammaglobulin therapy, intravenous
gastroenteritis
genetic neurologic disorders
glioblastoma multiforme(astrocytoma Gr.III)
glutamic acid decarboxylase, antibody
gram negative rod
gray matter
Guillain Barre syndrome
Guillain Barre syndrome, axonal form
Guillain Barre syndrome, complications
Guillain Barre syndrome, differential diagnosis of
Guillain Barre syndrome, etiology of
Guillain Barre syndrome, prognosis of
head injury
headache
herpes labialis
herpes simplex encephalitis
herpes simplex encephalitis, differential diagnosis of
herpes simplex encephalitis, recurrent
herpes simplex encephalitis, treatment of
herpes simplex myelitis
herpes simplex virus
herpes simplex virus infection, immunosuppressed patient
herpes simplex virus, human nervous system and
herpes simplex virus, localization of
herpes simplex virus, malignancy with
herpes simplex virus, pathogenesis of
herpes simplex virus, pathology of
herpes simplex, neurocutaneous lesions in
herpes virus
herpes virus infection
herpes zoster
herpes, genital
HLA
human herpesvirus 6
human T-lymphotropic virus type I(HTLV-I)
hydrocephalus
hypoglycorrhachia
imbalance
immunofluorescence
immunofluorescent exam of CSF cells
immunologic disease
immunology and the nervous system
immunosuppression
immunotherapy
inclusion bodies, intranuclear
inclusion body myositis
infection
infectious mononucleosis
infliximab
interferon
interferon beta 1-a
interferon beta 1-b
interferon inducer
intestinal biopsy
intracranial pressure, increased
intrauterine infection, viral
intrauterine infection, viral of CNS
iododeoxyuridine
JC virus
lateropulsion
leucine rich glioma inactivated 1 antibodies
level of consciousness, decreased
limbic encephalitis
limbic system
Lyme disease
lymphadenopathy
malformation, CNS, congenital
malignancy screen
malignancy, occult
memory, impairment of
meningitis
meningitis, aseptic
mental status, abnormal
microcephaly
micropthalmia
migraine
migraine, pathogenesis
migraine, prophylaxis
migraine, treatment of
monoamines
monoamines, brain
monoclonal antibodies
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, demyelinating disease
MRI, false negative
MRI, field strength, high
MRI, lesion burden
MRI, negative
MRI, ring sign
MRI, ring sign, open
MRI, spinal cord
MRS
multiple sclerosis
multiple sclerosis, children
multiple sclerosis, clinical patterns
multiple sclerosis, conjugal
multiple sclerosis, diagnosis of
multiple sclerosis, differential diagnosis of
multiple sclerosis, epidemiology of
multiple sclerosis, etiology of
multiple sclerosis, familial
multiple sclerosis, lesion location
multiple sclerosis, linoleic acid in
multiple sclerosis, monosymptomatic
multiple sclerosis, pathogenesis
multiple sclerosis, plaque
multiple sclerosis, relapsing
multiple sclerosis, risk factors for
multiple sclerosis, treatment of
multiple sclerosis, treatment of, first attack
muscle pain
myasthenia gravis
myasthenia gravis, etiology of
myasthenia gravis, paraneoplastic
myasthenic syndrome
myelitis
myositis
N-acetyl-L-aspartic acid
neoplasm, primary intracerebral
nerve conduction studies
neuroimmunology
neurologic disease
neurologic disease, diagnoses of
neurologic disease, multifocal
neurologic signs
neurologic symptoms
neurologic testing
neuromuscular disease, electrodiagnosis of
neuromuscular junction
neuronal cell surface antigen
neuronopathy, sensory
neuroophthalmology
neuropathology
neuropathology, brain
neuropathy, paraneoplastic
neuroprotective agents
NMDA antagonists
nonsteroidal anti-inflammatory drug
nystagmus
onconeural antibodies
opsoclonus-myoclonus syndrome
optic atrophy
papovavirus
parainfluenza virus
paraneoplastic cerebellar degeneration
peripheral nerve, lesion of
personality change
plasmapheresis
pleocytosis of cerebrospinal fluid
polyinosinic cytidic acid(poly IC)
polymerase chain reaction
polymyositis
polyneuropathy, chronic inflammatory demyelinating
post infectious polyneuropathy
postviral fatigue syndrome
precipitating factors
prognosis
progressive multifocal leucoencephalopathy
progressive neurologic disorder
psychiatric problems in neurologic disorders
psychomotor retardation
psychosis
Red flags
remote effect of cancer on the nervous system
respiratory tract infection
retinopathy
retrovirus
reversible neurologic disorder
review article
rheumatoid arthritis
rheumatoid arthritis, neurologic complications of
risk factors
rituximab
rubella virus
rubeola virus
safety
screening
seizure
seizure, psychomotor-temporal lobe
serologic testing
seronegative
serotonin agonist
sinusitis
spinal cord, lesion of
spirochete infection
steroid therapy, CNS treatment and complications with
stool culture
stress, emotional
subacute myelo-opticoneuropathy(S.M.O.N.)complex
subtemporal decompression
sun exposure
talk
temporal lobe, lesion
temporal lobe, lesion, bilateral
tetanus toxoid
transient neurologic deficit
transplacental virus infections
trauma
treatment of neurologic disorder
trigeminal neuralgia
trigeminovascular system
triptans
tumor necrosis factor
tumor necrosis factor inhibitor
twins
ultraviolet light
vaccination, neurologic complications with
vaccine
viral infection
viral infection, CNS
visual loss
vitamin D
wheelchair
white matter disease
workup
Showing articles 600 to 650 of 4257 << Previous Next >>

Diagnostic Criteria for Multiple Sclerosis: 2005 Revisions to the "McDonald Criteria"
Ann Neurol 58:840-846, Polman,C.H.,et al, 2005

Pregnancy, Delivery, and Birth Outcome in Women with Multiple Sclerosis
Neurol 65:1961-1963, Dahl,J.,et al, 2005

Internuclear Ophthalmoplegia
Arch Neurol 62:714-717, Keane,J.R., 2005

FDA Public Health advisory-Suspended Marketing of Tysabri (natalizumab)
www.fda.gov/cder/drug/advisory/natalizumab.htm.,(Feb 28), US Food and Drug Admin., 2005

Enhanced Benefit of Increasing Interferon Beta-1a Dose and Frequency in Relapsing Multiple Sclerosis
Arch Neurol 62:785-792, Schwid,S.R.,et al, 2005

Triaging Transient Ischemic Attack and Minor Stroke Patients Using Acute Magnetic Resonance Imaging
Ann Neurol 57:848-854, Coutts,S.B.,et al, 2005

Recommended Standard of Cerebrospial Fluid Analysis in the Diagnosis of Multiple Sclerosis, A Consensus Statement
Arch Neurol 62:865-870, Freedman,M.S.,et al, 2005

Life-Threatening Acute Pancreatitis Associated with Interferon Beta-1a Treatment in Multiple Sclerosis
Neurol 65:170-171, Midgard,R.,et al, 2005

Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis
NEJM 353:369-374,414,432, Kleinschemidt-DeMasters,B.K. &Tyler,K.L., 2005

Progressive Multifocal Leukoencephalopathy in a Patient Treated with Natalizumab
NEJM 353:375-381, Langer-Gould,A.,et al, 2005

Vagal Nerve Stimulation Effect on Cerebellar Tremor in Multiple Sclerosis
Neurol 65:499, Marrosu,F.,et al, 2005

Polyneuropathy Associated with Interferon Beta Treatment in Patients with Multiple Sclerosis
Neurol 65:456-458, Ekstein,D.,et al, 2005

Effect of Mitoxantrone on MRI in Progressive MS, Results of the MIMS Trial
Neurol 65:690-695, Krapf,H.,et al, 2005

Recent Use of Oral Contraceptives and the Risk of Multiple Sclerosis
Arch Neurol 62:1362-1365, Alonso,A.,et al, 2005

Pregnancy Outcomes During Treatment with Interferon Beta-1a in Patients with Multiple Sclerosis
Neurol 65:802-806, Sandberg-Wollheim,M.,et al, 2005

Randomized, Controlled Trial of Cannabis-Based Medicine in Central Pain in Multiple Sclerosis
Neurol 65:812-819,788, Rog,D.J.,et al, 2005

Neurologic and Developmental Disability at Six Years of Age After Extremely Preterm Birth
NEJM 352:9-19, 71, Marlow,N.,et al, 2005

Migraine and Cerebral White Matter Lesions
The Neurologist 11:19-29, Gladstone,J.P. &Dodick,D.W., 2005

Is Optic Neuritis More Benign Than Other First Attacks in Multiple Sclerosis?
Ann Neurol 57:210-215, Tintore, M., et al, 2005

Treatment of Early Onset Multiple Sclerosis With Subcutaneous Interferon Beta-1a
Neurol 64:888-890, 778, Pohl,D., et al, 2005

Modafinil for Fatigue in MS
Neurol 64:1139-1143, Stankoff,B.,et al, 2005

Anti-a4 Integrin Therapy for Multiple Sclerosis
Neurol 64:1336-1342, Rice,G.P.A.,et al, 2005

Mitoxantrone for Multiple Sclerosis in Clinical Practice
Neurol 63(Suppl 6):S25-S27, Rizvi,S.A.,et al, 2004

Mitoxantrone Treatment of Multiple Sclerosis
Neurol 63(Suppl 6):S28-S32, Cohen,B.A. &Mikol,D.D., 2004

Oligodendroglioma and Multiple Sclerosis. A Case Report.
Neurocirugia (Astur) 15:378-83, de la lama,A.,et al, 2004

Multiple Sclerosis and Gliomas. Clinical Remarks on 10 Cases and Critical Review of the Literature.
J Neurosurg Sci 48:129-33, Isadori,A.,et al, 2004

Neurologic Manifestations in Primary Sjogren Syndrome: A Study of 82 Patients
Medicine 83:280-291, Delalande,S.,et al, 2004

Treatment of Trigeminal Neuralgia Associated with Multiple Sclerosis
Neurol 63:1714-1715, Rasche,D.,et al, 2004

The Neurological and Cognitive Sequelae of Cardiac Arrest
Neurol 63:1774-1778, Lim,C.,et al, 2004

Interferon beta-1b in Secondary Progressive MS
Neurol 63:1779-1787,1768, Kappos,L.,et al, 2004

Interferon beta-1b in Secondary Progressive MS
Neurol 63:1788-1795,1768, The North American Study Group on Interferon beta-, 2004

Clinical Characteristics of African Americans vs Caucasian Americans with Multiple Sclerosis
Neurol 63:2039-2045, Bree,B.A.C.,et al, 2004

IV Immunoglobulins as Add-on Treatment to Methylprednisolone for Acute Relapses in MS
Neurol 63:2028-2033, Sorensen,P.S.,et al, 2004

A Serum Autoantibody Marker of Neuromyelitis Optica: Distinction from Multiple Sclerosis
Lancet 364:2106-2112, Lennon,V.A.,et al, 2004

Long-Term Brain Magnetic Resonance Imaging Changes After Optic Neuritis in Patients Without Clinically Definite Multiple Sclerosis
Arch Neurol 61:1538-1541, Optic Neuritis Study Group, 2004

Intravenous Immunoglobulin Treatment Following the First Demyelinating Event Suggestive of Multiple Sclerosis
Archn Neurol 61:1515-1520, Achiron,A.,et al, 2004

Intravenous Immunoglobulin in Secondary Progressive Multiple Sclerosis: Randomised Placebo-Controlled Trial
Lancet 364:1149-1156, Hommes,O.R.,et al, 2004

The Bioavailability of IV Methylprednisolone and Oral Prednisone in Multiple Sclerosis
Neurol 63:1079-1080, Morrow,S.A.,et al, 2004

Donepezil Improved Memory in Multiple Sclerosis in a Randomized Clinical Trial
Neurol 63:1579-1585, Krupp,L.B.,et al, 2004

The Prevalence of Pain in Multiple Sclerosis, A Multicenter Cross-Sectional Study
Neurol 63:919-921, Solaro,C.,et al, 2004

Interferon Beta-1a for Brain Tissue Loss in Patients at Presentation with Syndromes Suggestive of Multiple Sclerosis: A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 364:1489-1496,1463, Filippi,M.,et al, 2004

Randomized Controlled Trial of Yoga and Exercise in Multiple Sclerosis
Neurol 62:2058-2064, Oken,B.S.,et al, 2004

Neurologic Impairment 10 Years After Optic Neuritis
Arch Neurol 61:1386-1389, Optic Neuritis Study Group, 2004

The Natural History of Recurrent Optic Neuritis
Arch Neurol 61:1401-1405, Pirko,I.,et al, 2004

European Study on Intravenous Immunoglobulin in Multiple Sclerosis
Arch Neurol 61:1409-1412, Filippi,M.,et al, 2004

Familial Multiple Sclerosis and Other Inherited Disorders of the White Matter
The Neurologist 10:201-215, Kalman,B. &Leist,T.P., 2004

Role of Magnetic Resonance Imaging Within Diagnostic Criteria for Multiple Sclerosis
Ann Neurol 56:273-278, Miller,D.H.,et al, 2004

Clinical Implications of Benign Multiple Sclerosis: A 20-Year Population-Based Follow-Up Study
Ann Neurol 56:303-306, Pittock,S.J.,et al, 2004

The Effect of Cannabis on Tremor in Patients with Multiple Sclerosis
Neurol 62:1105-1109, Fox,P.,et al, 2004

Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004



Showing articles 600 to 650 of 4257 << Previous Next >>